Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Trichomoniasis

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.

Candidiasis

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...

Microbiota of the Urogenital Tract

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...

Vagina

Vagina

The vaginal canal is a tubular structure averaging about 10 cm in length that acts as the entryway to the female reproductive system and the passageway for menstrual flow and childbirth. The interior walls of the vagina exhibit concentric folds called rugae and are topped by an area known as the fornix, which connects with the protruding cervical portion of the uterus. This canal is comprised of an external fibrous layer, a muscular middle layer, and an inner lining with mucosal rugae, which...

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

Appendicitis

Appendicitis

Appendicitis is an acute inflammatory condition of the vermiform appendix, most commonly caused by obstruction of its lumen. The appendix is a narrow, blind-ended pouch that extends from the cecum, making it particularly prone to obstruction. Causes include fecaliths, lymphoid hyperplasia (often after viral infections), parasites, tumors, or foreign bodies. This obstruction initiates a cascade of pathological changes.Luminal Obstruction and Early InflammationAfter obstruction, normal mucosal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Anaphylaxis and Epinephrine Use in Pregnancy.

The journal of allergy and clinical immunology. In practice·2026

Same author

Suicidality in Postpartum Women With Unipolar and Bipolar Depression: A Secondary Analysis Comparing Self-Reported and Clinician Assessments.

The Journal of clinical psychiatry·2025

Same author

Mirtazapine for Severe Nausea and Vomiting During Pregnancy: Case Presentations and Recommendations.

Journal of clinical psychopharmacology·2025

Same author

Perinatal psychiatry: balancing maternal-fetal exposures to mental disorders and drug treatments.

Seminars in perinatology·2025

Same author

Changes in S-Citalopram Plasma Concentrations Across Pregnancy and Postpartum.

Clinical pharmacology and therapeutics·2025

Same author

Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset.

Journal of clinical psychopharmacology·2024

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

Published on: May 25, 2022

Atrophic vaginitis.

Catherine S Stika¹

¹Department of Obstetrics & Gynecology, Northwestern University, Feinberg School of Medicine, 680 North Lake Shore Drive, Chicago, IL60611, USA. c-stika@northwestern.edu

Dermatologic Therapy

|September 28, 2010

Summary

Menopause causes vulvovaginal atrophy, leading to debilitating symptoms in many women. Topical estrogen therapies and vaginal moisturizers effectively treat these menopausal changes and associated symptoms.

Area of Science:

Gynecology
Menopause research
Vaginal health

Background:

Menopause leads to estrogen loss, causing vulvovaginal mucosal changes.
Atrophic vaginitis affects 10-47% of postmenopausal women with debilitating symptoms.
Symptoms include dryness, pain during intercourse, itching, recurrent UTIs, and discharge.

Purpose of the Study:

To review the effects of menopause on vulvovaginal health.
To discuss the efficacy of treatments for atrophic vaginitis.

Main Methods:

Literature review on menopausal changes and treatment outcomes.
Analysis of studies on topical estrogen therapies, moisturizers, and lubricants.

Main Results:

Topical estrogen replacement therapies effectively reverse mucosal changes.

More Related Videos

Modeling Healthy and Dysbiotic Vaginal Microenvironments in a Human Vagina-on-a-Chip

Modeling Healthy and Dysbiotic Vaginal Microenvironments in a Human Vagina-on-a-Chip

Published on: February 16, 2024

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

Related Experiment Videos

Last Updated: Jun 8, 2026

Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

Models of Murine Vaginal Colonization by Anaerobically Grown Bacteria

Published on: May 25, 2022

Modeling Healthy and Dysbiotic Vaginal Microenvironments in a Human Vagina-on-a-Chip

Modeling Healthy and Dysbiotic Vaginal Microenvironments in a Human Vagina-on-a-Chip

Published on: February 16, 2024

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Recurrent Escherichia coli Urinary Tract Infection Triggered by Gardnerella vaginalis Bladder Exposure in Mice

Published on: December 4, 2020

Vaginal moisturizers and lubricants offer symptomatic relief for dryness and dyspareunia.

Conclusions:

Atrophic vaginitis is a common consequence of menopause-related estrogen loss.
Topical estrogen and supportive therapies are effective management options for symptom relief.